Background: This prespecified subgroup analysis of the FIDELIO-DKD trial aimed to evaluate the efficacy and safety of finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes melli
Introduction: Dipeptidyl peptidase-4 (DPP4) inhibitors (gliptins) are commonly prescribed for glucose control in patients with advanced chronic kidney disease (CKD) in whom other oral gl
Adapted version of http://archive.ics.uci.edu/ml/datasets/Chronic_Kidney_Disease For all modifications please look at: https://github.com/theislab/ehrapy-datasets/tree/main/Chronic_Kidney_Disease<b
